RxDoctor Payments Data

Mark Borigini

Rheumatology · Downey, CANPI 1043257082

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $919,548 of the $919,548 with a category attached, or 100.0%. Otsuka Pharmaceutical Co., Ltd. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2023 is the largest year on record at $347,780, more than ten times the $300 reported in 2019. Among rheumatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$919,548in general payments, 2019–2025

Across 79 payments — averaging $11,640 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Co., Ltd.$919K
  • GSK$300

What the payments were for

  • Consulting fees$919,548100%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka Pharmaceutical Co., Ltd.78$919,248
GSK1$300

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$919,548 in reported general payments places this provider in the 95th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Other rheumatology in Downey

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →